The ‘myth of Hydroxychloroquine (HCQ) as post-exposure prophylaxis (PEP) for the prevention of COVID-19’ is far from reality Deba Prasad Dhibar Navneet Arora Arnab Ghosh ArticleOpen Access7 Jan 2023 Scientific Reports Diagnostic performance between in-house and commercial SARS-CoV-2 serolog...
The pDC response is particularly impaired in severe COVID-19 patients. Overall, we propose that pDC activation is essential to control SARS-CoV-2-infection. Failure to develop this response could be important to understand severe cases of COVID-19....
In children, while acute COVID symptoms are generally mild, a multisystem inflammatory syndrome in children (MIS-C) assumed to be a delayed hyperimmune response to SARS-COV-2 infection/exposure has been reported [15]. Cardiovascular manifestations in MIS-C can range from vasodilatory or cardiogeni...
By using both classification (i.e., supervised) and clustering (i.e., unsupervised) algorithms, changes in user opinions and perceptions over time and across different regions were tracked and a moderate strength of relationship between exposure to social media content and individual perceptions was...
Additional host- and exposure-related factors may have played roles in the lack of infections in these flats. 3.3. Measured upward spread along the façade When the tracer gas was released on the balcony of Flat 812 (close to the water basin), there was a noticeable increase in gas ...
exposure to more risk are prone to negative affect [37]. Negative affect refers to the negative emotional response about the given risk [38]. In this study, it refers to the negative affect of Chinese citizens when faced with COVID-19, such as fear or worry. In a study by Griffin et...
Contacts included were adults with a recent history of exposure and absence of COVID-19-like symptoms within the 7 days preceding enrolment. Viral load of contacts, measured by quantitative PCR from a nasopharyngeal swab, was assessed at enrolment, at day 14, and whenever the participant ...
The aim of this study was to assess postacute coronavirus disease 2019 (COVID-19) syndrome (PACS) symptoms according to the onset of the infection while evaluating the effect of COVID-19 vaccination on the symptoms of PACS. We conducted a retrospective single-center cohort study in which non...
for sociodemographic factors, previously reported symptoms and over 80 comorbidities. This enabled us to assess the independent association between exposure to SARS-CoV-2 and the reporting of symptoms ≥12 weeks after infection, after accounting for many important confounders. A further strength is the...
Any or all symptoms can appear between two to 14 days after exposure to the virus,according to the US Centers for Disease Control and Prevention. But many doctors find most people will show signs of the disease within a week,Scaffner said. ...